Continue to attract well-known companies to settle in, and more and more new drugs are gradually approved for marketing
[Manufacturing Transfer Tracking] "Haikou Medicine Valley" has become a highland of Hainan's pharmaceutical industry cluster
reading tips
Yaogu Industrial Park, located in Haikou National High-tech Industrial Development Zone, Hainan Province, with its unique geographical advantages and many preferential policies, has established a "corporate secretary" system and accelerated the establishment of priority channels for review and approval to help companies understand policies in a timely manner. It has attracted many well-known pharmaceutical companies to build factories here.
As of 2021, there are 66 pharmaceutical companies, 19 medical device companies, and 1,590 pharmaceutical registration numbers in the park; the total output value of the pharmaceutical industry in Haikou City accounts for more than 97% of the province, and the high-tech zone accounts for more than 80% of Haikou City.
Bottle washing, filling, freeze-drying, capping, lamp inspection, palletizing, labeling, boxing... A batch of products in the second workshop of injections can achieve an output of 140,000 bottles.
On March 29, the reporter came to Hainan Beite Pharmaceutical Co., Ltd. in Yaogu Industrial Park, Haikou National High-tech Industrial Development Zone, Hainan Province. The workers on the assembly line were busy.
Not only Hainan Better Pharmaceuticals, but Yaogu Industrial Park has also attracted well-known pharmaceutical companies such as Qilu Pharmaceuticals to build factories here.
The Yaogu Industrial Park in the Haikou National High-tech Zone is the core area of "Haikou Pharmaceutical Valley". It integrates the existing pharmaceutical industry resources in Haikou City, and is dominated by the production and manufacture of biomedicine and health care products. It has become a highland for the pharmaceutical industry cluster in Hainan.
As of 2021, there are 66 pharmaceutical companies, 19 medical device companies, and 1,590 pharmaceutical registration numbers in the park; the total output value of the pharmaceutical industry in Haikou City accounts for more than 97% of the province, and the high-tech zone accounts for more than 80% of Haikou City.
Building a nest to attract phoenixes, more and more star enterprises have settled down
How to attract companies to settle in the "Medicine Valley" and stay?
"First of all, there must be good policies. There are many preferential policies in Hainan. Buying imported materials from Hainan has advantages over other provinces, and the local administrative approval is faster. You can also rely on Hainan's geographical advantages to better expand the international market." Liu Zhengguang, head of Better Pharmaceutical Co., Ltd., said.
In 2017, Bite Pharmaceutical, one of the top 100 enterprises in China's pharmaceutical industry, came to Hainan from Sichuan through investment promotion and established Hainan Bite Pharmaceutical Co., Ltd.
The reporter learned that Haikou National High-tech Zone has established a "corporate secretary" system in order to better serve the enterprises in the park.
They serve as corporate secretaries for enterprises and projects with cadres above the middle level of the management committee, and provide services for enterprises in terms of registration, construction, talent introduction, intellectual property rights, financing loans, debt issuance or listing counseling.
In addition, Haikou accelerated the establishment of priority channels for review and approval, and provided "one-to-one" policy consultation for major innovative varieties, first imitation varieties, new drugs in the field of transplantation, and imported drugs related to the medical and aesthetic industry in the pioneer area. Such measures can help enterprises to timely A thorough understanding of the policy is conducive to the gathering of various resources such as talents and supporting industries, and promotes the steady development of enterprises in many aspects.
Industrial agglomeration, many famous enterprises are developing rapidly
"At present, there are nearly 30 varieties under development, and many of the products are the first generic drugs or major clinical varieties in the country. In the past two years, the company's generic drugs have been approved for two, and four varieties have passed or are deemed to have passed the consistency evaluation. Among them, Two products, Azithromycin for Injection and Esomeprazole Sodium for Injection, successfully won the bid for the fifth batch of national centralized procurement." Liu Zhengguang said.
Qilu Pharmaceutical (Hainan) Co., Ltd., which has been committed to the fields of anti-tumor, cardiovascular and cerebrovascular, and small molecule targeted drugs, is a star enterprise in the "Drug Valley". It is the first company in Hainan Province to pass the "double certification" of the United States and the European Union. It is also the first pharmaceutical company in Hainan Province to export injections to the United States.
The company has successively established 74 projects with strong innovation and good curative effect, meeting important clinical needs, and has targeted the introduction of 7 leading talents in the pharmaceutical field with considerable influence overseas, forming a research and development team of more than 100 people. , to provide a steady stream of fresh blood for the company's development.
The company's annual R&D budget accounts for more than 8% of its sales revenue. It has successfully developed 34 new products and has 86 invention patents.
Liu Wenmin, chairman of Qilu Pharmaceutical (Hainan) Co., Ltd., introduced that the small molecule targeted drug gefitinib tablet, which was launched in December 2016, has broken the foreign monopoly after 7 years of research and development, reducing the drug price from more than 5,000 yuan per box to 247 yuan per box. Yuan/box has become a medicine that the common people can use and afford.
According to local conditions, continue to provide high-quality services for enterprises
In the future, Hainan Better Pharmaceutical will build a "high-end sterile preparation production base" to ensure that at least 5 new products are launched every year, and strive to complete the main construction of the B factory area by the end of 2022, and officially put into operation in the first half of 2023; achieve a breakthrough in operating income within 3 years. The target of 2.5 billion yuan has become one of the important pillar production bases supporting the development of the group company.
Regarding the current development in the "Medicine Valley", Liu Zhengguang believes that due to the particularity of Hainan's geographical location, the cost of electricity and logistics has increased, and the high-end talents needed are far less than those in Beijing, Shanghai and Guangzhou, and professional and technical talents are relatively in short supply.
Cai Lun, chairman of Hainan Xinshitong Pharmaceutical Co., Ltd., the first private pharmaceutical factory in Haikou, expressed the hope that private enterprises can get more attention, especially in terms of corporate loan interest, and hope to get more support.
The relevant person in charge of Haikou City said that Haikou will continue to do a good job in serving the enterprise in the future, and formulate corresponding measures to assist in solving the problem according to the needs and difficulties of the enterprise.
At the same time, with the vigorous development of the construction of the Hainan Island Free Trade Port, the "Medicine Valley" enterprises will also usher in another "spring" of development.
Reporter: Lai Shuwen